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Background: Pisa Syndrome or Pleurothotonus is a relatively rare truncal dystonia, characterized by tonic flexion of
the trunk and head to one side with slight rotation of the body. Since frequently associated to specific drugs such
as antipsychotics and cholinesterase inhibitors or to Parkinson Disease, a pathophysiological role of cholinergic-
dopaminergic imbalance has been suggested. We report here the first case of Pisa Syndrome due to an extracerebral
pathology as subdural haematoma.
Case presentation: A hypertensive patient was admitted to Our Department for subacute onset of tonic flexion and
slight rotation of the trunk associated to progressive motor deficit in left upper limb after a mild head trauma without
loss of consciousness occurred around three month before. No previous or current pharmacological interventions with
antidepressant, neuroleptic or anticholinergic drugs were anamnestically retrieved. Familiar and personal history was
negative for neurological disorders other than acute cerebrovascular diseases. Acutely performed cerebral MRI with
DWI showed a voluminous right subdural haematoma with mild shift of median line. After surgical evacuation, both
motor deficit and truncal dystonia were dramatically resolved. At one-year follow up, the patient did not develop any
extrapyramidal and cognitive signs or symptoms.
Conclusions: According to many Authors, the occurrence of truncal dystonia during several pharmacologic treatments
and neurodegenerative disorders (such as Alzheimer disease and parkinsonian syndromes) supported the hypothesis
that a complex dysregulation of multiple neurotransmitter systems are involved. We suggest a possible role of basal
ganglia compression in pathogenesis of truncal dystonia by means of thalamo-cortical trait functional disruption and
loss of proprioceptive integration. A further contribution of the subcortical structure displacement that alters motor
cortex connectivity to basal ganglia may be postulated.
Keywords: Pisa Syndrome, Subdural Haematoma, Parkinsonism, Cholinergic-dopaminergic imbalance, Proprioceptive
integration, Motor cortex connectivityBackground
First described by Ekbom in early 1972 [1], Pisa Syndrome
(PS) or Pleurothotonus is a relatively rare global dystonia
characterized by tonic flexion of the trunk and head to one
side with slight rotation of the body [2]. Female gender,
old age and organic brain disorders such as parkinsonisms
and dementia are considered its most common risk factors* Correspondence: docpask@yahoo.com
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article, unless otherwise stated.[2]. During past decades, it was report both in patients
taking typical/atypical antipsychotic agents [3] and in idio-
pathic cases or during neurodegenerative diseases such as
Parkinson Disease (PD) [4] and other parkinsonisms [5,6].
More recently, an association with cholinesterase inhibi-
tors [7], selective serotonin re-uptake inhibitors and other
antidepressants [8,9], antiepileptic as valproic acid [10] or
antiparkinsonian agents as dopamine-agonists [11,12] has
been accounted, suggesting a pathophysiological role of
cholinergic-dopaminergic imbalance in the regulation of
axial muscle tone [13]. To date, only one case of secondary
PS unrelated to exposure to psychotropic medications has
been reported in a patient with idiopathic normal pres-
sure hydrocephalus (iNPH) in which a dysregulation oftral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Patient in standing position before intervention.cph.
A slight but sustained tonic flexion of the trunk to the left side was
present in standing position with ipsilateral forward rotation. Vertical
axis highlights the left lateral skew of the trunk. Horizontal line
reflects the forward rotary motion of the left shoulder.
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here a case of PS in a patient with subacute subdural
haematoma (SDH) that was reverted by evacuation
intervention.
Case presentation
A 76 years-old hypertensive man was admitted to the
Department of Neurosciences of Neurological Center of
Latium in September for recent onset of slowly progressive
weakness in left upper limb and postural instability. He
also was observed walking with a tilt toward the left during
the last week because of slight rotation of the trunk. The
patient referred a mild head trauma without loss of
consciousness occurred around three months before. No
history of major operations, neurological disorders or drug
and alcohol abuse was reported. Hypertension was treated
by means of ramipril 5 mg/day and amlodipine 10 mg/day
for more than 5 years with an optimal control of pressure
values. No other previous or current pharmacological
interventions were anamnestically retrieved, including with
antidepressant, neuroleptic or cholinesterase inhibitors
drugs. Family history was negative for neurological
disorders other than acute cerebrovascular diseases. Both
laboratory studies (liver and kidney function, serum electro-
lytes, lipids, coagulation, haemachrome) and electrocardio-
grams were within normal ranges. Neurological examination
revealed motor deficits in left hand grip and forearm
flexion associated to sustained tonic 15-degrees lateral
flexion of the trunk to the left side with slight forward
rotation (see Figure 1). Abnormal posture of the trunk
worsened in walking and was reduced in lying. We also
observed left lateropulsion and difficulty in maintain
Romberg position after eyes closure. We did not find sig-
nificant changes in muscle tone or limb agility impairment,
such as cerebellar signs and symptoms were not elicited.
Tremor was not present at rest or during action or pos-
tural maintaining. Acutely performed cerebral Magnetic
Resonance Imaging (MRI) with Diffusion Weighted
Imaging (DWI) showed a voluminous right frontal,
temporal and parietal subdural haematoma with a diam-
eter of 28 mm. Ipsilateral ventricle was compressed with
8 mm shift of median line (Figure 2). A minimal amount
of haematic shedding (3 mm diameter) was also present
in left frontal subdural space. In T2-weighted images,
some periventricular hyperintense areas and a right
cerebellar lacunar focus were observed as probable expres-
sion of microvascular pathology. After neurosurgical
evaluation, the patient underwent surgical evacuation
by means of single burr hole drainage under the local
anesthesia and positioning of a soft silicon drain, which
was removed within 2 days. Twenty-four hours after the
intervention, neurological examination was negative
and tonic flexion of the trunk was dramatically improved
(Figure 3). We obtained postoperative ComputerizedTomography scans within 3 days after surgery that
showed a minimal residual hygroma. Four days after
intervention, both dystonic deviation and lateropulsion
disappeared and the patient was dismissed. No neuro-
logical deficit was evident at 12-months follow up, with
particular regard of extrapyramidal and cognitive signs
or symptoms.
Figure 2 Axial T2-weighted slice of cerebral MRI. A voluminous right frontal, temporal and parietal subdural haematoma with a diameter of
28 mm was present with ipsilateral ventricle compression and an 8 mm shift of median line. A minimal amount of haematic shedding (3 mm
diameter) was also present in left frontal subdural space. Some periventricular hyperintense areas were observed as probable expression of
microvascular pathology.
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Although the pathophysiology of PS is poorly under-
stood, the implication of monoamines has been widely
suggested [13,15]. According to many Authors, the oc-
currence of truncal dystonia during several pharmaco-
logic treatments and neurodegenerative disorders (such
as Alzheimer disease and parkinsonian syndromes) sup-
ported the hypothesis that a complex dysregulation of
multiple neurotransmitter systems are involved [13,16].
Both an excess of cholinergic transmission and a de-
crease of dopaminergic tone could be implied in some
cases because of causative effect of cholinesterase inhib-
itors and/or antagonist effects of neuroleptics on type-2
dopamine (D2) and type-2 serotonin (5HydroxyTriptamine,
5HT-2) receptors [15]. Down-regulation of postsynaptic
norepinephrine (NE) and 5HT-2 receptors induced by
antidepressant drugs may also determine a dysfunction of
brain stem pathways involved in axial tone control [17]. In
parkinsonian syndromes, PS and other lateral truncal
dystonia has been related not only to pharmacological
treatment, but also to the clinical stage of the disease [18].
An imbalance in the dopaminergic-cholinergic system, de-
pending both on the progression of nigrostriatal pathology
and on pharmacological treatment has been postulated inPD [18,19]. Supporting the neurotransmitters hypothesis,
efficacy of anticholinergic drugs and switching therapy to
less cholinergic antipsychotics, such as quetiapine or
clozapine has been described in some reports [15]. To our
knowledgement, this is the first case of secondary PS not
related to both pharmacological intervention and neuro-
degenerative disorders. In our patient, there was no per-
sonal or family history of cerebral degenerative disorders
or specific previous and current pharmacological treat-
ments other than antihypertensive drugs ramipril and
amlodipine. Otherwise MRI revealed wide compression
phenomena of subcortical structures and a significative
shift of median line. The previously reported case of PS
with no previous exposure to specific drugs was related to
an iNPH in which brain asymmetry seems to affect neuro-
transmitters function by means of a downregulation of D2
receptors in the striatum due to nigrostriatal dopamin-
ergic pathways alteration [14,20,21]. In this case, a possible
role of functional disruption of non-dopaminergic systems
such as thalamo-cortical tract through the corona radiata
may be hypotized. Experimental results suggest that axial
posture impairment in PD are related to progressive loss
of propioceptive integration during spatial orientation
tasks despite the integrity of vestibular system [22]. Some
Figure 3 Patient in standing position after intervention.
Four days after haematoma evacuation, both tonic trunk flexion and
weakness in left upper limb dramatically improved until complete
resolution. The patient maintained adequate standing position and
did not swerve to the left during walking.
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mechanisms of postural orientation and stabilization might
explain both dystonic phenomena and instability in PD
patients [4,19,22]. In our case, tonic flexion of the trunk
was indeed associated to left lateropulsion and static and
dynamic postural instability suggesting such an impair-
ment of sense of position and more generally a lateralizedpropioceptive dysfunction [22]. Compressive effect of SDH
on the afferent fibers to primary somatosensory cortex
from ventral posterolateral nucleus of the thalamus may
account for a subtle loss of the sense of position and
movement and an impairment of proprioceptive integra-
tion resulting in an impairment of the control of body
orientation [16,21]. Furthermore, a complex contribution
of basal ganglia in postural control and body rotation may
be postulated according to several lesion studies that
accounted for uncontrolled axial posture after controlateral
lesion of caudate and lenticular nucleus [4,18]. Displace-
ment of subcortical structure in our patients may alter
motor cortex connectivity to basal ganglia with consequent
reduction of inhibition pathways to sensory-motor cortex
because a particular involvement of unilateral caudate and
lenticular nuclei [4,16,22].
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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